PATENT CLAIM ANALYSIS

Application Number: 16070279
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["546", "293000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease, containing, as an active ingredient, a pyridinol derivative or a pharmaceutically acceptable salt thereof. A pyridinol derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof has an excellent colitis inhibitory effect in an inflammatory bowel disease model, and thus can be useful as a medicine for preventing or treating inflammatory bowel disease.

Claim (Index 8):
The compound according to  claim 1 , wherein the pharmaceutically acceptable salt is the form of an acid addition salt formed by an organic acid selected from the group consisting of oxalic acid, maleic acid, fumaric acid, malic acid, tartaric acid, citric acid and benzoic acid, or an inorganic acid selected from the group consisting of hydrochloric acid, sulfuric acid, phosphoric acid and hydrobromic acid.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 95.0
- Lexical Diversity: 1.61702
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12096432', '14784957', '10932463', '12021638', '15382872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8317053911504634
- 35 USC 102 Novelty (BERT): 0.4903717660682289
- Combined Prediction Score: 0.79757202864224
- Mean Citation Score: 284.06497
- Max Citation Score: 291.67694
- Similarity Product: 286.40025793504

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test